Screening for Chronic Hepatitis C Virus in Hospitalized Patients

NACompletedINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

November 22, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Hepatitis C
Interventions
DIAGNOSTIC_TEST

Hepatitis C, serology

Inclusion of patients in conventional hospitalization at Saint Joseph Hospital. Each consenting patient benefits from a screening HCV serology carried out during a biological sample indicated by his state of health. In the case of positive HCV serology, an additional sample will be taken in search of viral replication. All detectable HCV PCR patients will be admitted to hepatology consultation for assessment of liver status including non-invasive methods and possible treatment according to the conditions of the Marketing Authorization and recommendations for routine clinical practice. Data on management (treatment or non-treatment and treatment outcome: prolonged virological response 12 weeks after completion of treatment) will be collected.

Trial Locations (1)

13008

Hopital Saint Joseph, Marseille

All Listed Sponsors
lead

Hospital St. Joseph, Marseille, France

OTHER

NCT04437277 - Screening for Chronic Hepatitis C Virus in Hospitalized Patients | Biotech Hunter | Biotech Hunter